Arrowhead Pharmaceuticals Inc (ARWR)

Exchange
NASDAQ
Symbol
ARWR
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Country
USA

Stock price

At close: October 4, 2024

  • Open
    19.01
  • High
    19.27
  • Low
    18.68
  • Close
    18.82
  • Volume
    669,491

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
23.34
Working capital turnover
0.95
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
15.64
Fixed asset turnover
0.50
Total asset turnover
0.27
 Liquidity ratios
Current ratio
3.73
Quick ratio
3.46
Cash ratio
3.46
Cash conversion cycle
-15.64
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
3.90
Interest coverage
-13.27
 Profitability ratios
Gross profit margin
34.21%
Operating profit margin
-180.08%
Pretax margin
-178.85%
Net profit margin
-178.52%
Operating return on assets (Operating ROA)
-47.81%
Return on assets (ROA)
-47.39%
Return on total capital
-172.38%
Return on equity (ROE)
-185.04%